Evelyn Mcclelland, General Practice Medicare: Not Enrolled in Medicare Practice Location: 5257 S Wadsworth Blvd, Littleton, CO 80123 Phone: 303-743-5855 |
Ms. Linda Rotz, General Practice Medicare: Not Enrolled in Medicare Practice Location: 5257 S Wadsworth Blvd, Kaiser Permanente, Littleton, CO 80123 Phone: 303-972-5454 |
Rachel R Digmann, General Practice Medicare: Not Enrolled in Medicare Practice Location: 7600 Shaffer Pkwy, Littleton, CO 80127 Phone: 303-743-5855 |
Theda A Nadrash, General Practice Medicare: Not Enrolled in Medicare Practice Location: 5555 E Arapahoe Rd, Littleton, CO 80122 Phone: 303-850-6903 |
Dr. Christian Martin Stob, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 191 E Orchard Rd, Suite 200, Littleton, CO 80121 Phone: 303-788-3100 |
Dr. Stephanie M Campbell, PHARMD General Practice Medicare: Not Enrolled in Medicare Practice Location: 5257 S Wadsworth Blvd, Littleton, CO 80123 Phone: 303-972-5384 |
Lisa Rohrberg, General Practice Medicare: Not Enrolled in Medicare Practice Location: 5257 S Wadsworth Blvd, Littleton, CO 80123 Phone: 303-743-5855 |
Dr. Jeremy Jacob John, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 13402 W Coal Mine Ave Ste 300, Littleton, CO 80127 Phone: 303-963-0566 |
News Archive
A rescue inhaler can be a lifesaver during an asthma or COPD flareup, but using a rescue inhaler is complicated and misuse is common, putting patients' lives at risk. An education strategy, called teach-to-goal, may help patients use their inhalers properly during these critical times, according to research published online ahead of print in the American Thoracic Society journal Annals of the American Thoracic Society.
"The Obama administration is sending $250 checks to more than 300,000 older Americans who paid higher drug costs in the Medicare coverage gap known as the 'doughnut hole,' officials announced Thursday. The one-time, tax-free checks are the first tangible benefit of the health care package that became law this year."
Researchers at UC Davis and Ionis Pharmaceuticals have developed a hybrid treatment that harnesses a monoclonal antibody to deliver antisense DNA to acute lymphoblastic leukemia (ALL) cells and that may lead to less toxic treatments for the disease.
Catheters, intravenous lines, and other types of surgical tubing are a medical necessity for managing a wide range of diseases. But a patient's experience with such devices is rarely a comfortable one.
The approval is granted for both types of the disease – HBeAg-positive and HBeAg-negative chronic hepatitis B. Pegasys offers the hope of a treatment-free life for thousands of people with chronic hepatitis B as this innovative drug has been shown to achieve lasting remission for a significant proportion of patients.
› Verified 4 days ago